High-dose-rate interstitial brachytherapy for liver metastases: first study from India

PURPOSE: To study the safety and efficacy of high-dose-rate interstitial brachytherapy (HDRIBT) in patients with liver metastases (LM). MATERIAL AND METHODS: Between 2009 and 2011, 10 patients with 12 metastatic lesions in the liver were enrolled in this prospective trial. All patients had either re...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Daya Nand, Thulkar, Sanjay, Sharma, Seema, Gandhi, Ajeet Kumar, Haresh, Kunhi Parambath, Gupta, Subhash, Rath, Goura Kisor, Julka, Pramod Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2013
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708149/
https://www.ncbi.nlm.nih.gov/pubmed/23878550
http://dx.doi.org/10.5114/jcb.2013.36175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708149/
https://www.ncbi.nlm.nih.gov/pubmed/23878550
http://dx.doi.org/10.5114/jcb.2013.36175

Ejemplares similares